Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
123 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
21 Recruiting Perioperative Anticoagulant Use for Surgery Evaluation Study
Condition: Atrial Fibrillation
Intervention:
22 Not yet recruiting Start or STop Anticoagulants Randomised Trial (SoSTART)
Conditions: Intracranial Hemorrhages;   Intracranial Hemorrhage, Hypertensive;   Subarachnoid Hemorrhage;   Subdural Hematoma;   Intraventricular Hemorrhage;   Atrial Fibrillation;   Atrial Flutter;   Small Vessel Cerebrovascular Disease;   Microhaemorrhage
Interventions: Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Acenocoumarol;   Drug: Phenindione;   Drug: Warfarin
23 Recruiting Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
Condition: Hematoma
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Apixaban
24 Recruiting Novel Oral Anticoagulants in Stroke Patients
Conditions: Ischemic Stroke;   Intracranial Hemorrhages
Intervention:
25 Recruiting New Oral Direct Anticoagulants in Patients 80 Years Old and Over : a Population Pharmacokinetics Study
Condition: Atrial Fibrillation
Intervention: Other: Plasma drug concentrations
26 Recruiting Venous Thromboembolism in Renally Impaired Patients and Direct Oral Anticoagulants
Condition: Renal Insufficiency
Interventions: Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Heparin;   Drug: VKA
27 Recruiting Glomerular Filtration Rate-Estimating Equations During Use of Direct Oral Anticoagulants in Elderly Patients
Conditions: Atrial Fibrillation;   Elderly Patients;   Chronic Kidney Disease
Intervention: Other: Blood sample
28 Recruiting Register for New Oral Anticoagulants
Condition: Anticoagulation Treatment
Intervention:
29 Recruiting Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
30 Recruiting Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
Condition: DOAC Eligible Subjects
Intervention: Device: TEG6s DOAC Cartridge
31 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)
Condition: Non Valvular Atrial Fibrillation (nv AF)
Interventions: Drug: Non-exposed group;   Drug: Exposed group
32 Recruiting Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Conditions: Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot
Interventions: Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
33 Not yet recruiting Use of Direct Oral Anticoagulants in UK
Condition: Stroke
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Dabigatran;   Drug: Apixaban
34 Recruiting EUS-FNA for Patients Taking Anticoagulants Without Heparin Bridge
Condition: Endoscopic Ultrasonography-guided Fine Needle Aspiration
Intervention: Procedure: Endoscopic ultrasonography-guided fine needle aspiration
35 Recruiting The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
Condition: Recurrent Pregnancy Loss
Interventions: Drug: Aspirin;   Drug: Heparin;   Drug: Prednisone;   Drug: Immunoglobulin;   Drug: Dydrogesterone
36 Recruiting Sequential Expansion of Comparative Effectiveness of Anticoagulants
Condition: Atrial Fibrillation
Intervention:
37 Not yet recruiting The Prospective Cohort Study on the Benefit-risk of Antithrombotic or Anticoagulant Therapy in Patients With Unruptured Intracranial Aneurysms Associated With Ischemic Heart Disease or Ischemic Cerebrovascular Disease
Conditions: Intracranial Aneurysm;   Natural History;   Ischemic Heart Disease;   Ischemic Cerebrovascular Disease
Intervention:
38 Recruiting PGE1 as Additive Anticoagulant in ECMO-Therapy
Conditions: Respiratory Distress Syndrome, Adult;   Extracorporeal Membrane Oxygenation
Interventions: Drug: Alprostadil;   Drug: 0.9% sodium chloride solution
39 Recruiting ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)
Condition: Diabetes
Interventions: Drug: Dabigatran;   Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Edoxaban;   Drug: Warfarin;   Drug: Acenocumarole
40 Recruiting Health-related Quality of Life in Patients on Anticoagulants
Condition: Atrial Fibrillation
Interventions: Drug: DOAC or VKA;   Drug: VKA

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.